Substituted alkanoic acids
AssigneeAventis Pharma S.A.
InventorsNeil Victor Harris, Garry Fenton
Life of this patent
Estimating the term…
Loading patent…
AssigneeAventis Pharma S.A.
InventorsNeil Victor Harris, Garry Fenton
Estimating the term…
The invention is directed to physiologically active compounds of general formula (I): 1 wherein:- 2 represents (i) a saturated 3 to 6 membered carbocycle, optionally substituted by one or more alkyl groups, (ii) indanyl or (iii) a saturated 4 to 6 membered heterocyclic ring; R1 represents R3Z1-Het- or R4N(R5)—C(═O)—NH—Ar1—; L1 represents an —R6—R7— linkage; R2 represents hydrogen, halogen, lower alkyl or lower alkoxy; L2 represents an alkylene linkage; Y is carboxy or an acid bioisostere; and their corresponding N-oxides or prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their corresponding N-oxides or prodrugs. Such compounds have valuable pharmaceutical properties, in particular the ability to regulate the interaction of VCAM-1 and fibronectin with the integrin VLA-4 (α4β1).
A compound of general formula (I):-
Dependencies are inferred from the claim text.